Michalski K, Kosmala A, Werner RA, Serfling SE, et al. Comparison of PET/CT-based eligibility according to VISION and TheraP trial criteria in end-stage prostate cancer patients undergoing radioligand therapy. Ann Nucl Med 2023 Oct 27. doi: 10.1007/s12149-023-01874.
PMID: 37891376